Our data showed that CM from HCC cells pre-treated with sorafenib and mtDNA significantly activated the TLR9 pathway in THP-1-derived macrophage or RAW264.7, respectively (Fig. 6D). Here, TLR9 is linked to hepatocellular carcinoma.